Stepped care to optimize pre-exposure prophylaxis (PrEP) efectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: A randomized control trial

HIV incidence among pregnant and postpartum women remains high in South Africa. Pre-exposure prophylaxis (PrEP) use remains suboptimal in this population, particularly during the postpartum period when women’s engagement with routine clinic visits outside PrEP decreases.